pol-103a
Vaccineexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Apr 1, 2012 (NCT01546571)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Melanoma cellsImmunity, active
immunity, active - melanoma cells
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pol-103a
- pol-103a
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01546571 | Phase 3 | Apr 1, 2012 | Polynoma LLC, University of Virginia |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Polynoma LLC | For profit | 1 | 1 | 1 | 2012 |
| University of Virginia | Academic/Hospital | 1 | 0 | 1 | 2012 |
2 organizations
Page 1 / 1